Clinical Trials Directory

Trials / Completed

CompletedNCT01585792

Double Blind Comparative Study of TAK-875

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Takeda · Industry
Sex
All
Age
20 Years
Healthy volunteers
—

Summary

The purpose of this study is to evaluate the efficacy and safety of treatment with TAK-875 in diabetic patients.

Conditions

Interventions

TypeNameDescription
DRUGTAK-875
DRUGTAK-875
DRUGGlimepiride
DRUGPlacebo

Timeline

Start date
2012-05-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-04-26
Last updated
2013-04-16

Locations

2 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT01585792. Inclusion in this directory is not an endorsement.

Double Blind Comparative Study of TAK-875 (NCT01585792) · Clinical Trials Directory